Ehlers Le (toadsphere1)

lth workers working in Basic Health Units need training and regular supervision to improve their knowledge on the care of dengue patients. Delays in seeking and accessing treatment for rifampicin-resistant tuberculosis (RR-TB) and multi-drug resistant (MDR-TB) are major impediments to TB control in high-burden, resource-limited settings. We prospectively determined health-seeking behavioural patterns and associations with treatment outcomes and costs among 68 RR-TB patients attending conveniently selected facilities in a decentralised system in Harare, Zimbabwe. From initial symptoms to initiation of effective treatment, patients made a median number of three health care visits (IQR 2-4 visits) at a median cost of 13% (IQR 6-31%) of their total annual household income (mean cost, US$410). Cumulatively, RR-TB patients most frequently first visited private facilities, i.e., private pharmacies (30%) and other private health care providers (24%) combined. Median patient delay was 26 days (IQR 14-42 days); median health system delay was 97 days (IQR 30-215 days) and median total delay from symptom onset to initiation of effective treatment was 132 days (IQR 51-287 days). The majority of patients (88%) attributed initial delay in seeking care to "not feeling sick enough." Total delay, total cost and number of health care visits were not associated with treatment or clinical outcomes, though our study was not adequately powered for these determinations. Despite the public availability of rapid molecular TB tests, patients experienced significant delays and high costs in accessing RR-TB treatment. Active case finding, integration of private health care providers and enhanced service delivery may reduce treatment delay and TB associated costs. Despite the public availability of rapid molecular TB tests, patients experienced significant delays and high costs in accessing RR-TB treatment. Active case finding, integration of private health care providers and enhanced service delivery may reduce treatment delay and TB associated costs.This paper presents a study on copper production and distribution in Lower Austria's southeastern region during the Late Bronze Age (c. 1350-800 BC), with the focal point being the chemistry and isotopic character of artifacts from a small copper mining site at Prigglitz-Gasteil on the Eastern Alps' easternmost fringe. Ores, casting cakes, and select objects from the Late Bronze Age mining site at Prigglitz-Gasteil, Lower-Austria, and within 15 km of its surroundings, were chemically and isotopically analysed using XRF, NAA, and MC-ICPMS. The importance of Prigglitz-Gasteil as a local mining and metal processing center is evaluated based on the produced data, and the distribution and sourcing of copper-producing materials found at the site are discussed. Special attention is paid to the mixing of scrap and source materials early in the metal production process. The most salient discussions focus on the variability of the chemistry and Pb isotopic ratios of the studied objects, which seem to constitute a multitude of source materials, unlike the pure chalcopyrite-source copper produced from the Prigglitz-Gasteil mine itself. The analytical data suggests that copper alloys were mainly imported from materials originating in the Slovakian Ore Mountains, which were subsequently mixed/recycled with relatively pure locally produced copper. The purity of the copper from Prigglitz-Gasteil was fortuitous in identifying imported copper that contained measurable amounts of Pb and other chemically distinct characteristics. The chaîne opératoire of metal production at the site is mentioned; however, it is clear that additional information on the region's geochemistry is required before any finite conclusions on the ore-to-metal production can be made.Anemia remains an important global health problem. Inexpensive, accurate, and noninvasive solutions are needed to monitor and